Dendritic targeting of short and long 3′ UTR BDNF mRNA is regulated by BDNF or NT-3 and distinct sets of RNA-binding proteins by Annalisa Vicario et al.
ORIGINAL RESEARCH
published: 29 October 2015
doi: 10.3389/fnmol.2015.00062
Edited by:
Jean-Marc Taymans,
Jean-Pierre Aubert Research Center,
France
Reviewed by:
Nicole Déglon,
Lausanne University Hospital,
Switzerland
Carlos B. Duarte,
University of Coimbra, Portugal
*Correspondence:
Enrico Tongiorgi
tongi@units.it
Received: 09 April 2015
Accepted: 12 October 2015
Published: 29 October 2015
Citation:
Vicario A, Colliva A, Ratti A,
Davidovic L, Baj G, Gricman Ł,
Colombrita C, Pallavicini A, Jones KR,
Bardoni B and Tongiorgi E (2015)
Dendritic targeting of short and long
3′ UTR BDNF mRNA is regulated by
BDNF or NT-3 and distinct sets
of RNA-binding proteins.
Front. Mol. Neurosci. 8:62.
doi: 10.3389/fnmol.2015.00062
Dendritic targeting of short and long
3′ UTR BDNF mRNA is regulated by
BDNF or NT-3 and distinct sets of
RNA-binding proteins
Annalisa Vicario1, Andrea Colliva1, Antonia Ratti2,3, Laetitia Davidovic4, Gabriele Baj1,
Łukasz Gricman1, Claudia Colombrita2,3, Alberto Pallavicini1, Kevin R. Jones5,
Barbara Bardoni4 and Enrico Tongiorgi1*
1 Department of Life Sciences, University of Trieste, Trieste, Italy, 2 Laboratory of Neuroscience – IRCCS Istituto Auxologico
Italiano, Milano, Italy, 3 Department of Pathophysiology and Transplantation, “Dino Ferrari Center”, Università degli Studi di
Milano, Milano, Italy, 4 INSERM, IPMC – CNRS, UMR 7275, Valbonne, France, 5 Department of Molecular Cellular and
Developmental Biology, University of Colorado, Boulder, CO, USA
Sorting of mRNAs in neuronal dendrites relies upon inducible transport mechanisms
whose molecular bases are poorly understood. We investigated here the mechanism
of inducible dendritic targeting of rat brain-derived neurotrophic factor (BDNF) mRNAs
as a paradigmatic example. BDNF encodes multiple mRNAs with either short or long
3′ UTR, both hypothesized to harbor inducible dendritic targeting signals. However, the
mechanisms of sorting of the two 3′ UTR isoforms are controversial. We found that
dendritic localization of BDNF mRNAs with short 3′ UTR was induced by depolarization
and NT3 in vitro or by seizures in vivo and required CPEB-1, -2 and ELAV-2, -4. Dendritic
targeting of long 3′ UTR was induced by activity or BDNF and required CPEB-1 and the
relief of soma-retention signals mediated by ELAV-1, -3, -4, and FXR proteins. Thus, long
and short 3′ UTRs, by using different sets of RNA-binding proteins provide a mechanism
of selective targeting in response to different stimuli which may underlay distinct roles of
BDNF variants in neuronal development and plasticity.
Keywords: neurotrophins, brain-derived neurotrophic factor, dendrites, hippocampus, RNA transport, RNA
binding proteins, Fragile-X
INTRODUCTION
Subcellular compartmentalization of mRNAs is a mechanism enabling local synthesis of proteins
required for neuronal development and plasticity such as brain-derived neurotrophic factor
(BDNF; Tongiorgi et al., 1997; Steward and Schuman, 2001; Soule et al., 2006; Rodriguez
et al., 2008; Tongiorgi, 2008; Martin and Ephrussi, 2009). Although BDNF mRNA abundance
in dendrites is generally low, dendritic localization is enhanced in response to membrane
depolarization (Tongiorgi et al., 1997) or to BDNF itself (Righi et al., 2000). Evidence that
BDNF mRNA translation can occur in dendrites was provided by studies ex vivo using
neurosynaptosomes (Raju et al., 2011; Gharami and Das, 2014) and in vitro in hippocampal
neurons (An et al., 2008; Verpelli et al., 2010; Baj et al., 2011). The mechanism underlying BDNF
mRNA targeting to dendrites is poorly understood, partly because of the complexity of BDNF gene
regulation (Figure 1A, upper panel). Transcription of rodent BDNF gene produces 11 transcripts,
each with a diﬀerent alternatively spliced 5′ untranslated region (5′ UTR) and the same coding
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FIGURE 1 | Inducible targeting of endogenous BDNF mRNA in primary
hippocampal neurons. (A) Upper panel, illustration of the rat BDNF gene
structure with the 5′ UTR exons (light gray) and the coding sequence/3′ UTRs
exon (black); bottom panel, a schematic representation of the rat splice
variants according to the nomenclature proposed by Aid et al. (2007).
(B) Representative in situ hybridization (ISH) on control cultures and after 3 h
of 10 mM KCl, 50 ng/mL of NGF, BDNF, NT-3 and NT-4 stimulation; scale bar
10 μm. (C) Quantification of BDNF mRNA maximum dendritic distance
labeling (MDDL) in dendrites of treated neurons normalized to control neurons
upon different treatments with or without Trk inhibitor K252a (∗∗∗P < 0.001 vs.
control, Kruskal–Wallis one way ANOVA on Ranks followed by Dunn’s multiple
comparison test).
region (CDS; Figure 1A; Aid et al., 2007; Pruunsild et al., 2007).
These transcripts can exist in two isoforms, either with long
(3.2 Kb) or short (0.3 Kb) 3′ UTR (Figure 1A, bottom panel; Aid
et al., 2007; Pruunsild et al., 2007). There is general consensus that
most BDNF transcripts are restricted to the soma and proximal
dendrites (e.g., exons 1, 4) but selected variants are transported
distally (e.g., exons 2, 6) in an activity-dependent manner (An
et al., 2008; Chiaruttini et al., 2008, 2009; Aliaga et al., 2009; Baj
et al., 2013; Will et al., 2013).
To explain the mechanism of BDNF transcripts’ sorting,
two alternative models were proposed. The ﬁrst is a dualistic
mechanism by which somatic BDNF transcripts express the
short 3′ UTR while dendritic transcripts have the long 3′ UTR
(An et al., 2008). However, in rodent brain models, transcripts
containing exons 1, 2, 4, and 6 (formerly I, II, III, IV) are
expressed with long or short 3′ UTR in a 1:1 ratio and,
after kainic acid-induced seizures, transcripts having mainly the
short 3′ UTR are detected (Timmusk et al., 1993). Remarkably,
following seizures, exons 2 and 6 were detected in distal dendrites
(Chiaruttini et al., 2008; Baj et al., 2013). Our alternative model
is based on a tripartite combinatorial mechanism in which
“selector” signals are located in the 5′ UTR (for dendrite or soma
destination), a constitutively active dendritic targeting element
(DTE) mediated by Translin in the CDS, and activity-dependent
DTEs harbored in both long and short 3′ UTRs (Pattabiraman
et al., 2005; Chiaruttini et al., 2008, 2009; Aliaga et al., 2009;
Baj et al., 2011, 2013). In support of this model, BDNF mRNAs
with either 3′ UTRs were shown to be transported in dendrites
in response to neural activity (Oe and Yoneda, 2010; Baj et al.,
2011). Activity-dependent dendritic targeting of the 3′ UTR
short requires the RNA-binding protein (RBP) CPEB-1 (Oe and
Yoneda, 2010) while the targeting mechanism of the 3′ UTR long
was not investigated. Here, we investigated the dendritic targeting
mechanism of BDNF transcripts with long or short 3′ UTR,
demonstrating selective induction by BDNFor NT-3, respectively
thanks to interactions with distinct sets of RBPs.
MATERIALS AND METHODS
Chimaeric GFP Constructs
Total RNA was extracted from whole rat brain using TriZol R©
Reagent (Invitrogen). 1 μg of total RNA was reverse-transcribed
into cDNA and ampliﬁed with speciﬁc primer pairs. For details
on BDNF CDS-GFP chimera cloning (please see, Chiaruttini
et al., 2009). PCRs were performed with Phusion Hi-Fidelity
DNA polymerase (New England BioLabs) using speciﬁc primer
pairs and PCR conditions (reported in Supplementary Table
S1). A direct ampliﬁcation and cloning in pEGFP-N1 vector
(Clontech) was performed for BDNF 3′ UTRshort, 3′ UTRshort-
mutELAV-up, 3′ UTRlong, 3′ UTRmid and 3′ UTRend. For
3′ UTRshort-mutCPE and 3′ UTRshort-mutELAV-dw cloning,
an assembly strategy was adopted. Brieﬂy a ﬁrst round of PCR
was performed using the primer pairs for CPE and ELAV-
dw mutations (Supplementary Table S1). The second round of
PCR was performed using CPE and ELAV-dw mutant fragments
obtained in the ﬁrst round as forward “megaprimers” with
3′ UTRsh reverse primer to obtain mutated full length 3′
UTR short sequences. PCR fragments were then puriﬁed (PCR
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Cleanup kit from Sigma-Aldrich) and digested with XhoI/SacII
for BDNF coding sequence or NotI/HpaI for 3′ UTRs mutants.
All restriction enzymes were purchased from New England
BioLabs. Digested fragments were gel puriﬁed (PCR Gene Elute
kit from Sigma-Aldrich) and ligated (T5 DNA ligase from New
England BioLabs) over night at 16◦ with properly digested
pEGFP-N1 vector.
Protocol for CLIP
The CLIP (cross-linking and immunoprecipitation) assay for
ELAV was performed as previously described by Ratti et al.
(2006) and for FMRP was carried out using brains lysates
from wild type (WT) and Fmr1-KO mice as described by
Davidovic et al. (2011). Radiolabeled riboprobes for BDNF 3′
UTR sequences were obtained by transcribing pBluescript KS
containing BDNF 3′ UTR short, 3′ UTR mid, and 3′ UTR
end sequences. Oligos and conditions used for BDNF coding
sequence Reverse transcriptase-PCR on CLIP are reported in
Supplementary Table S1. PCR oligos and conditions used for
Pgk1 and Map1b were previously described by Edbauer et al.
(2010).
Bioinformatic Analysis
Analysis of evolutionary conserved regions in BDNF CDS and
3′ UTRs was performed using phastCons alignment software
(Siepel et al., 2005). The research of putative cis-elements for
RBPs on rat BDNF 3′ UTR sequence was performed using Bioedit
software (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The
RNA motifs reported in literature for the cited RBPs were
pairwise aligned on the target sequence and at least 80%
homology was set as threshold to deﬁne a putative cis-element.
RNAi Interference
RNAi interference (RNAi) “cocktails” against the diﬀerent RBPs
were generated by RNAseIII (Ambion) cleavage of relatively
long (∼300 nt) double-stranded RNA. Target regions of mRNA
encoding for RBPs were identiﬁed by consulting the NCBI data
base. To amplify the target regions, oligonucleotidic primers
containing the T7 promoter were used to amplify the target
regions and produce siRNA following manufacturer instructions.
Sequences and protocol are reported in Supplementary Table S2.
In order to evaluate RNAi “cocktails” eﬃcacy and speciﬁcity,
reverse transcriptase PCRwas performed on RNA extracted from
primary hippocampal cultures of rat neurons. To amplify the
targeted mRNAswe used oligonucleotidic primers containing the
same sequence designed for siRNA pools generation. Sequences
and protocol are reported in Supplementary Table S2. For
quantiﬁcation, PCR bands were scanned and quantiﬁed by
the Quantity One R© 4.6.6. software (Bio-Rad, Hercules, CA,
USA).
Cell Cultures
Primary rat and mouse hippocampal neurons were prepared
from P0 pups as previously described (Tongiorgi et al., 1997)
with slight modiﬁcations. Cells were plated on 2% Matrigel (BD
Biosciences) coated coverslips in 24-well plates at a density of
2 × 105 cells per well and cultured for 6 days in neurobasal
supplemented with B27 (Invitrogen) and pen/strep in a 5%
CO2-humidiﬁed incubator. The medium was changed every
2 days from the second day in culture onward. PC12 rat
pheochromocytoma cells, used to asses RBP siRNAs eﬃciency
and speciﬁcity, were cultured in RPMI medium supplemented
with 10% FBS, 5% Donor Horse Serum, 2 mM L-glutamine,
20 mM Hepes and antibiotics (Euroclone) and diﬀerentiated in
DMEM containing 1% horse serum, 1% Pen-Strep, and 50 ng/ml
NGF (Sigma). Cells were transfected with Lipofectamine2000TM
(Invitrogen) with 1 μg of plasmid DNA or 19 nM of
siRNA mixture (at 6 DIV for neurons or 75% conﬂuency for
PC12 cells). Neurons were depolarized as previously described
(Tongiorgi et al., 1997), or treated with diﬀerent neurotrophins
(BDNF, NT-3, NT-4; SIGMA) at a 50 ng/mL concentration in
culture medium. After 3 h of depolarization or neurotrophin
administration, cells were ﬁxed with PFA 4% for 15’ at RT.
Animal Treatment
Animals were treated according to the institutional guidelines
in compliance with the European Council Directive 86/609 and
NIH Guide for the Care and Use of Laboratory Animals. Animal
experiments on WT and BDNFlox/lox mice were authorized by
the Italian Ministero della Salute n. 185/2010-B d.d. 21/10/2010.
Twomonth old male C57/BL6 or BDNFlox/lox mice (Gorski et al.,
2003) were anesthetized with urethane (1 g/kg, i.p.) 30 min prior
to i.p. injection of 300 mg/kg pilocarpine or saline. Animals
were housed in groups under standard animal room conditions
(12:12 h light/dark cycle, ambient temperature 23◦C, ad libitum
access to food and water).
In situ Hybridization and Fluorescent In
situ Hybridization
In situ hybridization (ISH) on brain sections or cultures was
performed as previously described (Tongiorgi et al., 1997, 1998).
Cells were ﬁxed for 15 min at RT in 4% PFA in PBS, washed
in PBST, and permeabilized in absolute ethanol for 15 min at
−20◦C. After rehydration, cells were hybridized with antisense
or sense probes for GFP mRNA or BDNF CDS. The open
reading frame of GFP or BDNF CDS were subcloned into
pBluescript or pGEM vectors respectively and DIG- labeled
probes were synthesized with the DIG-RNA labeling kit (Roche
Diagnostics) using linearized plasmids as templates, according to
the manufacturer’s instructions. Hybridization was followed by
high stringency washes with 0.01x Sodium Saline Citrate buﬀer
containing 0.1% Tween20 (SSCT) at 60◦C, then coverslips were
incubated with anti-digoxigenin alkaline phosphatase coupled
antibody and developed with NBT and BCIP for 40 min at RT.
For ﬂuorescent in situ hybridization (FISH) after PFA ﬁxation
cells were incubated with H2O2/PBS 0.3% for endogenous
peroxydase quenching and then permeabilized with EtOH.
After probe hybridization and stringency washes, coversplis
were incubated with anti-digoxigenin horse-radish peroxidise
conjugated (Roche) diluted 1:300 in blocking solution at RT
for 1 h. HRP detection was performed using Tyramide System
Ampliﬁcation kit – Cyanin 3 coupled (Perkin Elmer) following
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manufacturer instructions. After three washes in TNT buﬀer,
cells were incubated with the primary antibodies against diﬀerent
RBPs diluted in PBST/FBS 5% (Supplementary Table S3). Nuclei
were stained with Hoechst 33342 and the coverslips were
mounted with Mowiol (Sigma). ISH on free-ﬂoating, 40 μm
coronal sections cut at the level of dorsal hippocampus was
performed as previously described (Tongiorgi et al., 1997,
1998). After permeabilization, sections were pre-hybridized at
55◦C for 1 h followed by an overnight incubation at 55◦C
with 100 ng/mL BDNF CDS antisense probe. ISH was stained
with the ﬂuorescent anti-DIG enhancer set (Roche diagnostics),
following manufacturer’s instructions. Sections were mounted in
anti-fade mounting solution (Invitrogen) and stored at 4◦C in
dark.
Confocal images of FISH on brain slices were acquired by
a Nikon Eclipse C1si confocal system mounted on a Nikon
TE-2000U inverted microscope. We used a Plan-Apochromat
20x/0.75(NA) and 60x/1.4(NA) oil-immersion objectives. The
resolution used was of 0.2 μm × 0.2 μm × 0.5 μm (XxYxZ) for
20X acquisitions and 0.08 μm × 0.08 μm × 0.25 μm (XxYxZ)
for 60X acquisitions. To obtain comparable signals between
control and treated conditions, confocal images were acquired
keeping the same acquisition settings for laser intensity, pmt
ampliﬁcation, pinhole aperture (33μm) and pixel dwell (0.48μs).
Immunohistochemistry
Brain-derived neurotrophic factor immunohistochemistry on
WT and BDNFlox/lox brain sections were performed on 2%
PFA perfused brains cut at 40 μm thick coronal sections,
as previously described (Tongiorgi et al., 2004). Slices were
developed through Nickel-enhanced diamminobenzidine (DAB)
chromogenic reaction for about 20–30 min at room temperature
in dark. All passages, except development, were performed in
gentle shaking.
Western Blots
Cells were collected in lysis buﬀer and the lysates were centrifuged
at 10000 rpm for 15 min at 10◦C to remove cellular debris.
Protein concentration was determined using Bradford assay.
Samples were resolved on 12% SDS-PAGE gels, loading 20 μg
of PC12 extracts. Proteins were transferred onto nitrocellulose
membrane (Schleicher&Schuell) and stained using the diﬀerent
antibodies (Supplementary Table S3). Membranes were then
washed 3 min × 5 min in 5% non fat milk in PBST
and incubated for 1 h at RT with the respective secondary
antibody (Supplementary Table S3) and membrane developed
with chemiluminescent substrate (ECL by GE Healthcare). X-ray
ﬁlms were scanned and quantiﬁed by the Quantity One R© 4.6.6.
software (Bio-Rad, Hercules, CA, USA).
Colocalization Analysis
Confocal images were acquired by a Nikon Eclipse C1 confocal
microscope mounted on a Nikon TE-2000U inverted microscope
using a Plan-Apochromat 60x/1.4 oil-immersion objective.
Sequential scanning laser was used to avoid cross talk between
diﬀerent ﬂuorochromes. Only pyramidal neurons with clear
dendrites were acquired, with a z-stack thickness of 200 nm (12
stacks). At least 21 neurons from three independent experiments
were measured for colocalization analysis. Regions of interest
(ROI) had a 10μm× 5μm× 2.4μm size located in the proximal
(10 μm far from soma) and distal (at least 60 μm far from soma)
compartments of apical dendrites. After ROI selection images
were cropped, then background was automatically subtracted
using Imaris software (Bitplane). Images were then deconvolved
using Huygens software with classical CMLE algorithm. “Coloc”
function of Imaris was used to perform colocalization analysis
Automatic threshold was applied to each image before Manders
coeﬃcients calculation. Images of colocalization between mRNA
and RBPs are Z-stack maximum projection of representative
dendrite shafts analyzed. The images were post-processed to
linearly increase brightness equally in the whole panel for
visualization purpose.
Quantitative Imaging Analysis and
Statistics of Non-radioactive In situ
Hybridization
Non-radioactive ISH was analyzed by viewing stained cultures
under bright-ﬁeld illumination as previously described
(Tongiorgi et al., 1997; Chiaruttini et al., 2009) with slight
modiﬁcations. In detail, individual preparations were coded and
analyzed in a blind manner with respect to treatments. Bona-ﬁde
pyramidal neurons were randomly sampled from each culture
and acquired by a Nikon AXM1200 digital camera on a Nikon
E800 Microscope with interference contrast-equipped lens
(60x magniﬁcation) and then analyzed with the image analysis
program ImageJ 1.44 (NIH) using the “Straighten” plugin.
Dendritic targeting of BDNF transcripts in apical dendrites of
pyramidal neurons was evaluated as the maximum distance of
dendritic labeling (MDDL) measured in μm from the soma
using the “Trace” function of the software Image-ProPlus 4.0
(Media Cybernetics). Straightened dendrites were “traced” in a
conservative manner, starting from the base of dendrite after
soma and up to the point in which in situ labeling was clearly
distinguishable. At least 150 neurons from four independent
experiments were measured for each condition. For both MDDL
analysis and semi-quantitative densitometric analysis of BDNF
mRNA ISH levels, we used standardized development time of
alkaline phosphatase reaction of 40 min at RT. Labeling intensity
was measured as a scale of gray levels from 0 = no staining to
255= saturated black staining, using the software Image-ProPlus
4.0 (Media Cybernetics) as previously described (Chiaruttini
et al., 2009). Background level for each dendrite was determined
by evaluation of the mean gray value in the distal portion of
apical dendrites of transfected neurons in which in situ labeling
was not present. Background staining was then substracted
from each dendrites before averaging. This procedure produces
densitometric data that are expressed in arbitrary units (or gray
levels). This densitometric method to quantify ISH does not
require signal normalization, as previously validated in ours
and other laboratories (An et al., 2008; Chiaruttini et al., 2009).
Statistical signiﬁcance among groups was evaluated performing
Kruskal–Wallis one-way ANOVA on ranks, followed by a
multiple comparison procedure with Dunn’s method.
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RESULTS
Inducible Dendritic Targeting of
Endogenous BDNF mRNA
We previously showed that neuronal depolarization and
BDNF induce dendritic localization of BDNF mRNA
in vitro (Tongiorgi et al., 1997; Righi et al., 2000), however,
it remained undetermined if other neurotrophins can
also induce BDNF mRNA localization in dendrites. To
investigate the eﬀect of neurotrophins we treated primary
rat hippocampal neurons at 6 days in vitro (DIV) for
3 h with NGF, BDNF, NT-3, NT-4 (50 ng/ml) or 10 mM
KCl. Endogenous BDNF mRNA was detected in isolated
cultured cells using non-radioactive ISH using a probe
targeting the CDS and hence recognizing all the possible
BDNF transcripts expressed (Figure 1A). Dendritic targeting
of BDNF transcripts was evaluated as the MDDL from
the soma, normalized to untreated condition. At least 150
neurons from four independent experiments were measured
for each condition. KCl treatment induced a 2.83 ± 0.17
fold increase of BDNF mRNA targeting with respect to
basal culturing conditions (Figures 1B,C). Stimulation with
BDNF and NT-3 induced also a signiﬁcant fold increase
compared to untreated cells (1.59 ± 0.11 and 1.49 ± 0.10,
respectively), while NGF and NT-4 did not signiﬁcantly alter
BDNF mRNA distribution along dendrites (Figures 1B,C).
Activity of neurotrophins and KCl solution used in these
experiments was demonstrated by translocation of c-fos
in the nuclei (Supplementary Figure S1). Blocking Trk
receptors activity with the inhibitor K252a prevented BDNF
mRNA dendritic translocation after application of BDNF or
NT-3 (Figure 1C). Inhibition of Trk signaling by K252a also
depressed KCl-dependent dendritic targeting, suggesting the
contribution of neurotrophin signaling during KCl-induced
neuronal depolarization, as previously described for BDNF
stimulation (Righi et al., 2000). These data provide strong
evidence that distal dendritic localization of endogenous
BDNF mRNA can be induced in hippocampal neurons by
depolarization, BDNF and NT-3.
Long and Short BDNF 3′ UTRs Respond
Differently to NT-3 and BDNF
We previously showed that upon treatment with high KCl,
the short 3′ UTR BDNF can target the mRNA of a reporter
gene to the distal dendrites of cultured neurons (Baj et al.,
2011). To investigate the role of short and long 3′ UTRs
with respect to the stimulation with activity, BDNF or
NT-3, primary rat hippocampal neurons were transfected with
GFP-3′ UTR short or GFP-3′ UTR long chimeras. Cultures
were stimulated for 3 h with 10 mM KCl or 50 ng/ml
of each neurotrophin, and neurons were subjected to non-
radioactive ISH using a DIG-labeled GFP antisense probe and
ﬁnally, the MDDL from the soma was measured (Figure 2).
No unspeciﬁc staining was detected using GFP sense strand
probes (Figure 2D, middle panel). In resting neurons, the
short 3′ UTR was mainly conﬁned in the proximal dendritic
FIGURE 2 | Inducible targeting of short and long BDNF 3′ UTR
chimeric mRNAs. ISH on hippocampal neurons transfected with either
GFP-3′ UTR short (A) or long (D) in unstimulated (control) and stimulated
conditions. (D) Central panel, control ISH using GFP sense probe on
transfected cells. Arrows indicate MDDL (MDDL); scale bar 10 μm. MDDL
quantification of BDNF 3′ UTR short (B) or BDNF 3′ UTR long (E) following
KCl (10 mM) and neurotrophins (50 ng/ml) treatments, alone or in combination
with the Trk inhibitor K252a (30 nM). Densitometric analysis of GFP mRNA
distribution along dendrite length (0–110 μm) in neurons transfected with
GFP-3′ UTR short (C) or long (F), in resting conditions of after treatment with
KCl, NT-3 or BDNF (∗∗∗P < 0.001 vs. control, Kruskal–Wallis one way ANOVA
on Ranks followed by Dunn’s multiple comparison test).
compartment (MDDL = 41.56 ± 0.82 μm) similar to
GFP mRNA (MDDL = 40.34 ± 1.72 μm; Figures 2A,B).
GFP mRNA localization was not modiﬁed by neuronal
depolarization (MDDL = 40.36 ± 1.87 μm), whilst GFP-
3′ UTR short mRNAs showed a signiﬁcant translocation
in distal dendrites both after high potassium depolarization
(MDDL = 80.57 ± 1.94 μm, P < 0.001) or treatment with NT-
3 (MDDL = 69.14 ± 1.61 μm, P < 0.001). NGF, BDNF or
NT-4 had no eﬀect on GFP-3′ UTR short mRNA localization
(Figures 2A,B). Trk tyrosine kinase inhibitor K252a abolished
the GFP-3′ UTR short dendritic localization in response to NT-
3 application, in accordance with the results previously seen
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for endogenous BDNF mRNA (Figure 2B). Similarly, KCl-
induced translocation was signiﬁcantly impaired, suggesting
that a NT3-dependent mechanism plays a substantial role in
activity-induced dendritic targeting of short 3′ UTR transcripts
(Figure 2B).
Localization of the GFP-3′ UTR long chimera did not diﬀer
signiﬁcantly from the GFP reporter alone in unstimulated
cultures (MDDL = 43.14 ± 1.36 μm). However, depolarization
induced strong accumulation of this mRNA in distal dendrites
(MDDL = 62.44 ± 1.44 μm, P < 0.001), similarly to the
short 3′ UTR constructs (Figures 2D,E). Furthermore,
application of 50 ng/ml BDNF (but not NT-3, NT-4 nor
NGF) induced dendritic translocation of the GFP-3′ UTR long
at distances comparable those induced by KCl depolarization
(MDDL = 61.38 ± 1.92 μm). K252a application abolished
BDNF-induced, and signiﬁcantly reduced KCl-dependent,
3′ UTR long mRNA distal targeting, suggesting that BDNF
signaling is required to enhance the depolarization eﬀect on
mRNA localization (Figure 2E). The ISH signals from the
very same neurons were quantiﬁed by densitometric analysis
throughout the entire dendritic length, leading to results
comparable to those obtained with MDDL measurements
(Figures 2C,F). Taken together, these results provide clear
evidence that both the long and short 3′ UTR sequences are
involved in inducible dendritic localization of BDNF mRNA.
Dendritic targeting of BDNF mRNA is modulated by neuronal
depolarization (KCl) for both regions but is speciﬁcally regulated
by NT-3 for the short 3′ UTR and by BDNF for the long 3′ UTR.
Activity-dependent Dendritic Targeting
of BDNF Short 3′ UTR mRNA In vivo
A previous study suggested that BDNF transcripts of BDNFlox/lox
mice, lacking a functional long 3′ UTR, are conﬁned in the
soma in vivo (An et al., 2008). However, activity-dependent
targeting in vivo of short 3′ UTR transcript was not evaluated.
To determine whether the short 3′ UTR form is targeted to
dendrites also in vivo, we took advantage of the same BDNFlox/lox
mouse model (Gorski et al., 2003). In WT mice in resting
conditions, BDNF mRNA was detected in the soma and in
the proximal dendrites of CA1 and CA3 neurons while in
BDNFlox/lox mice it was detectable only in the soma, as previously
described (An et al., 2008; Figure 3A). However, after treatment
with the pro-epileptic drug pilocarpine for 3 h, localization
of BDNF transcripts in dendrites was observed both in WT
and BDNFlox/lox hippocampi, conﬁrming the ﬁnding that BDNF
mRNA splice variants with a short 3′ UTR can be transported
in dendrites after stimulation (Figure 3A). Interestingly, in
BDNFlox/lox neurons a punctate distribution of BDNF mRNA
was observed, whilst a more uniform signal was seen in WT
animals. These diﬀerences may be due to the fact that the long
3′ UTR is lacking from distal compartments of BDNFlox/lox
neurons and therefore staining for BDNF mRNA is generally
weaker. BDNFlox/lox mice display decreased BDNF protein
dendritic levels despite the total amount of protein is comparable
(An et al., 2008). To test if pilocarpine treatment is able to increase
BDNF protein levels in BDNFlox/lox mice, brain sections from
FIGURE 3 | Endogenous BDNF 3′ UTR short localization in vivo.
(A) Representative images of fluorescent in situ hybridization (FISH) of
endogenous BDNF CDS in CA1 (upper panel) and CA3 (bottom panel) in wild
type (WT) and BDNFlox/lox transgenic mouse devoid of the long BDNF 3′ UTR
sequence (lox) in basal conditions (left) and upon 3 h of pilocarpine-induced
seizures (300 mg/kg, 3 h; right). Arrows indicate the maximal distance of
dendritic labeling. (B) Representative images of BDNF protein immunostaining
in CA1 area from the same brains used for FISH (A); scale bar, 20 μm for (A)
and 40 μm for (B).
WT and mutated animals were immunostained with an anti-
BDNF antibody. Hippocampal neurons of pilocarpine-treated
WT and BDNFlox/lox mice were found to display comparable
labeling in distal dendrites (Figure 3B), providing further
evidence that BDNF can reach distal dendrites even if it is
translated from transcripts expressing the 3′ UTR short only.
Multiple RNA Binding Proteins are
Associated to BDNF mRNA
Previous evidence showed that BDNF mRNA traﬃcking and
stabilization requires interaction with RBPs (Chiaruttini et al.,
2009; Oe and Yoneda, 2010; Louhivuori et al., 2011). To identify
the RBPs interacting with the 3′ UTR short or long, we used
an in silico approach to detect evolutionary conserved regions
and putative binding proteins sites on each 3′ UTR variant.
BDNF sequences were compared among primates, mammals,
and vertebrates (see Supplementary Figure S2) using phast Cons
alignment software (Siepel et al., 2005). Several regions were
found to be highly conserved (Figure 4A), with the short 3′
UTR region being the most conserved one, followed by the
mid and terminal regions of the long 3′ UTR. To recognize
binding motifs for RBPs, the bioinformatic analysis was focused
on regions highly conserved among vertebrate species, which
are more likely to share an evolutionary conserved biological
function. We searched for consensus recognition sequences
for some RBP families including cytoplasmatic polyadenylation
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FIGURE 4 | Brain-derived neurotrophic factor mRNA interaction with RNA binding proteins (RBPs). (A) Graphical view of homology of BDNF coding
regions and 3′ UTR among Primates, Mammals, and vertebrates. Similarity scores range from 0 (=no homology) to 1 (identical sequence). Numbers indicate the
nucleotide position of BDNF gene on chromosome 11. (B) Putative binding sites for RBPs indicated with different colors at the corresponding positions along BDNF
mRNA. Positions of the short 3′ UTR, long-mid 3′ UTR and long-end sequences used in UV-CLIP assays in (C) are also shown. (C, left panel) Reverse
transcriptase-PCR of BDNF mRNA immunoprecipitated with an antibody against the neuronal ELAV proteins (IP-16A11), or a control IgG antibody (IP-IgG) or no
antibody (IP-beads). Total brain RNA (Input) and no sample (Blank) were used as a positive and a negative control, respectively; (right panel) UV-CLIP assay with an
anti-neuronal ELAV proteins antibody (IP-16a11) to immunoprecipitate RNA-protein complexes formed in presence of murine brain protein lysate and radiolabeled
BDNF CDS, 3′ UTR short, or 3′ UTR long-mid and 3′ UTR long-end ribobrobes. As a negative control, UV-CLIP was performed using an anti-IgG antibody with a mix
of all the BDNF riboprobes used. (D) Immunoblot assay to test specificity of the anti-FMRP antibody in inputs and immunoprecipitates from WT and Fmr1 knockout
(KO) mice (left panel). Reverse transcriptase-PCR of BDNF mRNA recovered from immunoprecipitates from WT and Fmr1 knockout lysates upon CLIP assay (middle
panel). Map1b, a known mRNA target of FMRP protein, was used as a positive control, while Pgk1, an unrelated mRNA, as a negative control. Blank, no sample in
Reverse transcriptase-PCR reaction. (E) Colocalization analysis of endogenous BDNF mRNA with different RBPs. Immunofluorescence signal from the different
RBPs (green) and from endogenous BDNF mRNA (red) in proximal dendrites are shown separately (RBP, mRNA) and merged (MERGE). Images are Z-stack
maximum projection of 12 stacks confocal images. Scale bar: 1 μm. (F,G) Graphs report the Manders coefficient (Y-axis) of RBPs signal colocalized with
endogenous BDNF mRNA (F) and BDNF mRNA signal colocalized with the different RBP (G) in proximal (dark gray) and distal (light gray) dendrites. Data are
reported as mean ± SEM. Statistical significance of proximal vs. distal Manders coefficients of colocalization was evaluated performing t-test if the normality test was
passed, or Mann–Whitney Rank-Sum test (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001).
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element binding proteins (CPEBs), embryonic lethal abnormal
vision like proteins (ELAVs) and Fragile X mental retardation
protein (FMRP), which are known to bind to short, well-deﬁned
RNA sequences and are involved in RNA transport, translation,
and stabilization. The short 3′ UTR (nts 1–321) displays one
CPEB binding site and two diﬀerent conserved sites for ELAV
proteins (the upper 5′ site is referred here as to “ELAV up” and
the 3′ most as “ELAV down”; Figure 4B). Additionally, in this
region we found two other conserved sites, a Nanos response
element (NRE) and a CUG rich region representing a potential
target for Pumilio, a translational regulator (Wickens et al.,
2002), and for the CUG-binding protein (CUGBP), known to
regulate splicing, deadenylation, mRNA stability and translation
(Philips et al., 1998; Timchenko et al., 1999; Ladd et al., 2001;
Savkur et al., 2001; Paillard et al., 2003; Moraes et al., 2006;
Mori et al., 2008). Despite the high conservation degree of these
sequences, we did not consider Pumilio and CUGBPs in the
present study, since so far there are no clear reports assessing
their involvement in regulation of mRNA transport. Even if the
BDNF long 3′ UTR showed a higher degree of variability among
species when compared to the short 3′ UTR, three conserved
“hot spots” were identiﬁed (Figures 4A,B). The ﬁrst conserved
region, located at the boundary with the 3′ UTR short, presents
an “ELAV rich region” with a cluster of binding sites for the
ELAV-1 family member (HuR, red bars in Figure 4B). A nearby
second conserved sequence, in the center of the long 3′ UTR,
is characterized by a G-quartet like structure, known to be
recognized by FMRP (Darnell et al., 2001). Finally, a third region
located at the end of the long 3′ UTR shows a pattern of cis-
elements similar to the one found in the short 3′ UTR, with
CPEs and ELAV recognition sites. Additionally, we found one
BC1 (Rozhdestvensky et al., 2001) and several AU-rich response
element (AURE), especially in the 3′ terminal region of the long 3′
UTR, which support a previously suggested possible involvement
of hnRNPA2 RBP (Raju et al., 2011).
In order to detect an interaction of ELAVs with BDNF
transcripts, we performed a RNA immunoprecipitation (RIP)
assay on mouse brain lysates using a pan-neuronal ELAV
(nELAV) antibody, followed by Reverse transcriptase-PCR. This
analysis showed that BDNF mRNA was selectively recovered
from anti-nELAV immunoprecipitates (IPs), but not from
control-IgG IPs or in presence of beads alone (Figure 4C,
left panel). To test the speciﬁcity of binding of nELAVs to
the BDNF 3′ UTR sequence, we used radiolabeled riboprobes
corresponding to BDNF short 3′ UTR and CDS in UV Cross-
Linking Immunoprecipitation (UV-CLIP) assays with mouse
brain protein lysates. In addition, we used two riboprobes
corresponding to the central (mid, nts 890–1510) or terminal
(end, nts 2339–2790) regions of the 3′ UTR long sequence that
also contained ELAV consensus binding motifs (Figures 4B,C,
right panel). No RNA-protein complex formed in presence
of the CDS-speciﬁc riboprobe, whilst speciﬁc nELAV-BDNF
RNA complexes were recovered in presence the short, mid and
end 3′ UTR riboprobes (Figure 4C, right panel). To test for
FMRP binding, we performed similar CLIP experiments with
mouse brain lysates using a previously described polyclonal
rabbit anti-FMRP antibody (Davidovic et al., 2011). The
speciﬁcity of the anti-FMRP antibody used was ﬁrst proven
by immunoprecipitation assays using WT and FMR1 knockout
mouse brains as a negative control (Figure 4D, left). Accordingly,
endogenous BDNF mRNA could be ampliﬁed via Reverse
transcriptase-PCR from WT but not FMR1 knockout mouse
brains immunoprecipitates (Figure 4D, middle panel). Map1b
and Pgk1mRNAs were used as positive and negative controls for
FMRP binding, respectively (Figure 4D, right panel). Previous
studies already demonstrated that CPEBs physically bind to
BDNF CDS and 3′ UTR mRNA (Oe and Yoneda, 2010) and
therefore the binding experiments for these proteins were not
performed.
To verify if the above mentioned RBP are colocalized with
BDNF mRNA in dendrites, we performed double labeling
experiments with FISH against endogenous BDNF transcripts
coupled to immunoﬂuorescence (IF) for RBPs family members
in unstimulated cultures (Figure 4E). Tyramide Ampliﬁcation
System was employed to visualize endogenous BDNF mRNA
in distal dendrites, due to its intrinsic low abundance in such
compartment of resting cultured neurons (Baj et al., 2013; Will
et al., 2013). The diﬀerent RBPs taken in account in this study
showed a similar distribution in dendrites, suggesting that they
represent shared components of dendritic mRNA transporting
granules. In proximal dendrites (Figures 4E–G), in unstimulated
cultures, almost half of the staining spots of Translin, CPEB4,
ELAV1, ELAV2, and FMRP were colocalized with endogenous
BDNF mRNA (Manders coeﬃcient 0.415 ± 0.041, 0,424± 0.036,
0.475 ± 0.040, 0.465 ± 0.028, and 0.485 ± 0.023, respectively),
while other transporting granules were less colocalized, with
Manders coeﬃcient values ranging from 0.224 to 0.348. Similarly
BDNF mRNA signal results to be more colocalized in the
proximal compartment with Translin, ELAV1, ELAV2, ELAV3,
and FMRP granules (Manders coeﬃcient 0.417 ± 0.034,
0,420 ± 0.041, 0.440 ± 0.029, 0.444 ± 0.031, and 0.423 ± 0.024,
respectively). In distal compartments more than half of the
transporting granules stained for Translin were colocalized
with BDNF mRNA (Manders coeﬃcient 0.579 ± 0.035), while
other RBPs display similar colocalization degree with RNA,
except for the less colocalized ELAV3 and FXR2 (Manders
coeﬃcient 0.232 ± 0.026 and 0.240 ± 0.023, respectively).
Moreover, BDNF mRNA displayed the highest colocalization
rate with Translin protein (Manders coeﬃcient 0.436 ± 0.032)
conﬁrming its involvement in this mRNA traﬃcking as
previously demonstrated (Chiaruttini et al., 2009) while it showed
a heterogeneous colocalization with other RBPs (Manders
coeﬃcient ranging from 0.152 to 0.304). CPEB-1 and ELAV-4
were undetectable after FISH, therefore they have been omitted
in the colocalization analysis. Statistical comparison revealed
that RBPs colocalization with BDNF mRNA was signiﬁcantly
higher in distal dendrites than in proximal dendrites for
translin, CPEB2, CPEB3, while it was higher in proximal than
in distal for ELAV3 and FMRP, and was equally distributed
for CPEB4, ELAV1 and 2, and FXR2 (Figure 4F). Viceversa,
when colocalization was analyzed taking BDNF mRNA as
reference, we found that BDNF mRNA was signiﬁcantly more
localized with ELAV1, 2, 3, FMRP and FXR2 in proximal
dendrites than in distal (Figure 4G), suggesting that this mRNA
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and these RBPs interact more in the initial segment of the
dendrites.
Different Set of RBPs Regulates Long
and Short 3′ UTRs Dendritic Targeting
To test if the identiﬁed RBPs contribute to the inducible
mechanism of BDNF mRNA targeting to dendrites, dendritic
localization of GFP-BDNF 3′ UTRs was measured following KCl,
NT-3 or BDNF stimulation in neurons co-transfected with siRNA
cocktails against each member of the CPEB, ELAV, or FRXP
families. Analysis of siRNA eﬃcacy showed a high degree of
silencing of target RBPs (Figures 5A,D and 6F; Supplementary
Table S4). The speciﬁcity of siRNAs used and the lack of
oﬀ-target eﬀects among homologous members of the CPEB and
ELAV families were conﬁrmed by Reverse transcriptase-PCR
(Figures 5A,D; Supplementary Table S4). When considering
the short BDNF 3′ UTR, both activity-dependent and NT-
3 mediated localization of the reporter was found to require
CPEB-1 and CPEB-2, but not CPEB-3 or CPEB-4 (CPEB-1
siRNA KCl MDDL = 37.16 ± 1.12 μm, CPEB-2 siRNA KCl
MDDL = 37.48 ± 1.63 μm, ∗∗∗∗P < 0.001 respect to KCl
no siRNA; CPEB-1 siRNA NT-3MDDL = 37.69 ± 1.09 μm,
CPEB-2 siRNA NT-3 MDDL = 38.96 ± 1.18 μm, ###P < 0.001
respect to NT-3 with no siRNA). A control siRNA against
luciferase had no eﬀect on BDNF mRNA targeting (Figure 5B,
scramble). Disruption of the CPE binding site through site
FIGURE 5 | Role of CPEB and ELAV proteins in BDNF 3′ UTR short activity-dependent targeting. (A,D) Representative semiquantitative Reverse
transcriptase-PCR for CPEBs (A, upper panel) and ELAVs (D, upper panel) expression levels in control neurons (CTRL), and in neurons silenced with siRNA specific
for the indicated RBP or with a scramble siRNA (LUCIF) in comparison to those of total rat brain lysates, taken as positive control. GADPH expression level has been
reported for normalization. Representative western blots on lysates from control (−) or silenced (+) PC12 cells with the CPEB (A, bottom panel) and ELAVs (D,
bottom panel) -specific siRNAs. Tubulin was blotted for normalization. (B) MDDL quantification of ISH for GFP sequence on neurons transfected with GFP-3′ UTR
short construct upon specific silencing of CPEB family members (1, 2, 3, 4) in presence of KCl (10 mM) or NT-3 (50 ng/ml). Controls are represented either by cells
not treated with siRNAs or treated with a scramble siRNA (upper panel). (C) MDDL quantification of ISH for GFP sequence on neurons transfected with GFP-3′ UTR
short construct WT and mutated in the CPEB binding site (upper panel). Representation of transcripts used for the experiments (bottom panel). (E) MDDL
quantification of ISH for BDNF 3′ UTR short upon silencing of ELAV family members (1, 2, 3, 4) in presence of KCL (10 mM) or NT-3 (50 ng/ml) stimuli. Controls are
represented either by cells not treated with siRNAs or treated with a scramble siRNA (upper and bottom panel). (F) MDDL quantification of ISH for BDNF 3′ UTR
short WT or with mutated ELAV binding sites (upper panel). Representation of transcripts used for the experiments (bottom panel; ANOVA all vs. control with same
treatment, ∗∗∗P < 0.001; ###P < 0.001).
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 October 2015 | Volume 8 | Article 62
Vicario et al. Differential 3′ UTRs BDNF mRNA targeting
FIGURE 6 | Role of CPEBs, ELAVs, and FMRP proteins in BDNF 3′ UTR long activity-dependent targeting. (A–C) MDDL quantification of ISH for GFP
sequence on neurons transfected with GFP-3′ UTR long construct upon silencing of different RBPs (CPEB-1-4, A; ELAV-1-4, B; FMR1, FXR2, TRLN, hnRNPA2, C)
in resting conditions or after KCl (10 mM) or BDNF (50 ng/ml) treatment. Controls are represented either by cells not treated with siRNAs or treated with a scramble
siRNA (upper panel). (D) MDDL quantification of ISH for GFP sequence on neurons transfected with GFP-3′ UTR long construct containing full-length or final portion
(nt 2339-end) of BDNF 3′ UTR long in resting conditions or after KCl (10 mM) or BDNF (50 ng/ml) treatment. (E) MDDL quantification of ISH for GFP sequence on
neurons transfected with BDNF CDS-GFP and BDNF CDS-3′ UTR MID-GFP constructs, in resting conditions and after KCl (10 mM) or BDNF (50 ng/ml) treatment
(left panel). Graphical representation of the constructs used for the experiments is reported in the bottom right panel (ANOVA all vs. control with same treatment,
θθθP < 0.001; ∗∗∗P < 0.001; ###P < 0.001). (F) Representative western blots on lysates from control (−) or silenced (+) PC12 cells with FMRP, FXR2, Translin,
hnRNPA2/B1 specific siRNAs. Tubulin was blotted for normalization. (G) Schematic representation of GFP chimaeric transcripts.
directed mutagenesis (UUUUAU to CGAUCG, Figure 5C)
completely suppressed mRNA sorting in dendrites in response
to extracellular stimuli, and further conﬁrmed the role of CPEBs
in BDNF mRNA traﬃcking (Huang et al., 2006). However, it is
unclear whether CPEB 2 can bind directly to the mRNA, since
UUUUAU is the consensus sequence for CPEB-1, and a speciﬁc
CPEB-2 recognition site has not been described yet (Huang
et al., 2006). Both ELAV-2 and ELAV-4 were required for KCl
and NT-3-dependent transport of the 3′ UTR short (ELAV-2
siRNA KCl MDDL = 43.57 ± 1.99 μm, ELAV-4 siRNA NT-3
MDDL = 41.32 ± 1.39 μm, ∗∗∗P < 0.001 respect to no siRNA
KCl; ELAV-2 siRNA NT-3 MDDL = 42.53 ± 1.28 μm, ELAV-4
siRNA NT-3 MDDL = 41.48 ± 1.14 μm, ∗∗∗P < 0.001 respect
to no siRNANT-3; Figures 5E,F). The other two family members,
ELAV-1 and -3, did not result involved in dendritic localization
of BDNF 3′ UTR short. Involvement of ELAV-2 and-4 RBPs
was further conﬁrmed by the fact that disruption of either the
5′ or 3′ ELAV binding motifs (AUUUAU to AGCGCG) blocked
BDNF 3′ UTR short dendritic targeting upon stimuli (Figure 5F).
The relative RNA levels of these mutants were compared to
the parental GFP and WT GFP 3′ UTR short mRNAs to rule
out the possibility that the lack of dendritic localization of
the 3′ UTR mutants could be related to a decreased stability
or expression and indeed we did not observe any signiﬁcant
diﬀerence (Supplementary Figures S3A,B). In summary, these
results clearly demonstrate that KCl and NT-3 are able to induce
distal dendritic localization of BDNF 3′ UTR short through a
complex post-transcriptional regulatory mechanism that requires
the interaction of CPEB-1, CPEB-2, ELAV-2, and ELAV-4 RBPs.
A similar approach was used to identify key RBPs modulating
the long BDNF 3′ UTR localization in distal dendrites upon KCl
or BDNF stimuli. Dendritic targeting of the long isoform required
CPEB-1 but not CPEB-2, CPEB-3, or CPEB-4 in both conditions
(KCl MDDL = 48.84 ± 1.15 μm, ∗∗∗P < 0.001 respect to no
siRNA KCl, BDNF MDDL = 49.17 ± 1.55 μm, ###P < 0.001
respect to no siRNA BDNF; Figure 6A). Silencing of individual
ELAV family members induced an unexpectedly complex pattern
of responses. ELAV-1, -3, and -4 down-regulation promoted a
signiﬁcant increase in 3′ UTR long targeting after stimulation
and even at resting conditions, in particular following silencing
of ELAV-1 (ctrl MDDL = 59.90 ± 1.31 μm, θθθP < 0.001 respect
to ctrl no siRNA; KCl MDDL = 81.40 ± 1.64 μm, ∗∗∗P < 0.001
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respect to no siRNA KCl; BDNF MDDL = 78.36 ± 2.13 μm,
###P < 0.001 respect to no siRNA BDNF; Figure 6B). A similar
increase in dendritic targeting of the 3′ UTR long was found at
resting conditions also with siRNAs against the Fragile-X proteins
(FXRPs) FMRP1 and FXR2, consistent with our recent study on
total BDNF mRNA localization in Fmr1−/− mice (Louhivuori
et al., 2011; θθθP < 0.001, Figure 6C). Interestingly, activity- or
neurotrophin-induced dendritic targeting was normal in absence
of FMRP or FXR2 (Figure 6C). Additionally, the role of other
two RBPs, Translin and hnRNPA2/B1 was tested. Translin was
used as an internal control since this protein does not appear
to be involved in the sorting of 3′ UTR long while hnRNPA2/B
was tested since putative AURE recognition elements have been
identiﬁed in the terminal part of the 3′ UTR long. No signiﬁcant
alterations of BDNF 3′ UTR long mRNA targeting were observed
after Translin or hnRNPA2/B1 silencing (Figure 6C). These
ﬁndings suggest that a speciﬁc set of RBPs is able to retain 3′
UTR long-containing splice variants in the proximal dendritic
compartment of resting neurons while other RBPs are involved in
the dendritic targeting. These “soma-restrictive” proteins display
clustered recognition sites in the 3′ UTR long central region
which is remarkably well-conserved throughout the evolution
(nts 890–1510, Figure 4B) while RBPs involved in the dendritic
targeting appeared located mostly at the 3′ end of long 3′ UTR
region (nts 2339–2790, Figure 4B).
The Long 3′ UTR Contains Two Distinct
RNA Localization Signals with Opposing
Functions
We speculated that the central region of the 3′ UTR long
might contain a retention signal, able to counteract both the
constitutive dendritic targeting signal in the coding region of
BDNF mRNA (Chiaruttini et al., 2009) and the inducible signal
present in the terminal part of the 3′ UTR long. To test this
hypothesis, the terminal 3′ UTR long sequence (nts 2339–2790)
was inserted at the 3′ of the GFP reporter (GFP-3′ UTR END,
Figure 6G). This chimera displayed an increased distal targeting
with respect to the full length 3′ UTR long under basal conditions
(MDDL = 63.96 ± 1.93 μm, OOOP < 0.001 respect to ctrl
3′ UTR long), comparable to that observed when ELAV-1, -
3, or -4 were silenced (compare Figures 6D and 6B). At the
same time, both KCl and BDNF induced a small but signiﬁcant
increase in distal transport of the terminal 3′ UTR long sequence
with respect to the full-length 3′ UTR long (3′ UTR END KCl
MDDL = 73.41 ± 2.61 μm, ∗∗∗P < 0.001 respect to KCl 3′
UTR long; 3′ UTR END BDNF MDDL = 75.79 ± 1.88 μm,
###P < 0.001 respect to BDNF 3′ UTR long, Figure 6D).
To test the role of the central region of the 3′ UTR long,
the sequence 849–1533 nt was cloned downstream the GFP
reporter (GFP-3′ UTR MID, Figure 6G). The 3′ UTR MID
fragment did not respond to any stimulus suggesting the absence
of DTE while the CDS fragment was constitutively localized
in dendrites (Figure 6E). However, when the central region
was inserted at the 3′ end of the CDS-GFP construct (CDS-
GFP-3’MID, Figure 6G; Chiaruttini et al., 2009), it completely
suppressed the constitutive dendritic localization of the CDS
(CDS-GFP-MID ctrl MDDL= 39.65± 0.91μmvs. CDS-GFP ctrl
MDDL= 57.25± 2.0μm, θθθP< 0.001, Figure 6E). Notably, this
retention signal was relieved by BDNF (CDS-GFP-MID BDNF
MDDL = 61.85 ± 1.63 μm), but not by stimulation with KCl
(CDS-GFP-MID KCl MDDL = 45.17 ± 1.28 μm, ∗∗∗P < 0.001
respect to KCl GFP-CDS, Figure 6E).
DISCUSSION
This study provides evidence of dendritic transport of both short
and long BDNF 3′ UTR variants and unravels the core molecular
mechanisms underlying inducible dendritic targeting of these
two BDNF mRNA forms. A remarkable outcome of this study is
the strikingly selective response to NT-3 for short 3′ UTR and to
BDNF for long 3′ UTR. Activity- and NT3-dependent dendritic
targeting of 3′ UTR short requires CPEB-1,2 and ELAV-2,4 while
dendritic targeting of long 3′ UTR relies on a more complex
mechanism. This includes BDNF-dependent release of soma-
retention signals mediated by ELAV-1,3,4, FMRP and FXRP2,
and KCl/BDNF-activation of inducible targeting signalsmediated
by CPEB-1.
We found that Neurotrophin-3 activates dendritic targeting of
BDNF short 3′ UTR and BDNF activates the long 3′ UTR form.
NT-3 was previously shown to be able to redistribute mRNAs
to distal dendrites in cultured neurons but the mechanism has
remained unknown (Knowles and Kosik, 1997). In addition,
NT-3 is known to promote beta-actin mRNA localization
within axonal growth cones through a mechanisms requiring
blockade of microtubule depolymerisation following activation
of cAMP-dependent protein kinase A (PKA; Zhang et al., 1999).
A remarkable ﬁnding of our study is that NT-3 can regulate the
traﬃcking selected isoforms of BDNF. The reciprocal interplay
between BDNF and NT-3 has been previously investigated
in vitro and in vivo (Lindholm et al., 1994; McAllister et al., 1997;
Patz and Wahle, 2006). BDNF and NT-3 have been shown to
play counteracting eﬀects in regulating cortical dendritic growth
during development (McAllister et al., 1997). Interestingly,
the receptor for NT-3, TrkC, is the earliest neurotrophin
receptor expressed during brain development, followed by a later
expression of TrkB (Bernd, 2008). Moreover, in visual cortex NT-
3 mRNA levels, detected prenatally, dramatically decrease at later
stages of development, with an opposing trend for BDNF mRNA
(Lein et al., 2000; Patz andWahle, 2006). BDNF and NT-3, which
act presumably by activating TrkB and TrkC receptors, coupled
to activation of similar signaling mechanisms, have diﬀerential
eﬀects on dendritic targeting of BDNF mRNAs. Previous studies
suggest, however, that mRNA dendritic transport activated by
NT-3 or BDNF may be induced through diﬀerent mechanisms
which also govern protein translation at synapses (Leal et al.,
2014). For instance, while it was previously shown that BDNF
promotes the transport of its own mRNA along dendrites
through a PI3K-dependent mechanism (Righi et al., 2000), NT-3
was shown to induce dendritic traﬃcking of beta-actin mRNA
through a PKA-dependent mechanism (Zhang et al., 1999).
There is a general consensus that BDNF mRNA levels in distal
dendritic processes are low both under resting conditions and
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after stimulation in vitro and in vivo (Tongiorgi et al., 1997,
2004; An et al., 2008; Will et al., 2013). It has been proposed
that BDNF mRNA is present in low amounts in dendrites, most
likely because of a short half-life compared to other dendritic
mRNAs (Will et al., 2013) and it has been suggested that neuronal
activity may selectively increase stability of the long 3′ UTR BDNF
mRNA by interactions with the RBP ELAV-1/HuD (Fukuchi
and Tsuda, 2010; Allen et al., 2013). However, a previous study
showed that BDNF short and long 3′ UTR variants are equally
stabilized by activity (Fukuchi and Tsuda, 2010) and interactions
of ELAV-1/HuD with the short 3′ UTR were described (Lim and
Alkon, 2012). The lack of eﬀect of KCl depolarization on BDNF
mRNA decay in our conditions, suggests that its increase in
dendrites is due to active transport rather than increased stability.
Collectively, these previous studies and the results presented here,
suggest that the most likely cause of the low levels of BDNF
mRNA observed in distal dendrites is the result of a tight activity-
dependent regulation of transport, which limits the quantity of
BDNF mRNA available in dendrites.
Neither short nor long BDNF 3′ UTR mRNAs were found
to require CPEB3 or CPEB4 for their dendritic localization.
This is an interesting result, since both these CPEB-family
members were shown to be required for synaptic plasticity and
dendritic spine changes in Aplysia and mouse, through a prion-
like mechanism which confers these proteins the ability to form
dynamic aggregates (Fioriti et al., 2015), and which does not
appear to be involved in BDNF mRNA traﬃcking. Another
peculiar aspect of CPEB3 is that it has been recognized as
self-cleaving ribozyme throughout the evolution (Salehi-Ashtiani
et al., 2006), which may explain why we and others (Morgan
et al., 2010) found low cellular levels of this mRNA by PCR,
in front of clearly detectable protein levels by western-blot and
immunoﬂuorescence.
We provide conclusive in vitro and in vivo evidence that BDNF
transcripts with a short 3′ UTR can be targeted to dendrites in an
activity-dependent manner by binding to CPEB-1, as previously
suggested by two diﬀerent laboratories (Oe and Yoneda, 2010;
Baj et al., 2011). In addition, we show here that inducible
dendritic targeting of the 3′ UTR short requires also ELAV-2
and -4. Interaction between the two ELAV sites on the short 3′
UTR may explain why the absence of either ELAV-2 or ELAV-
4 leads to disruption of mRNA short targeting in dendrites. It
has been suggested that ELAV-2-4 dimerization may allow the
formation of RNA transporting granules able to interact with the
cytoskeleton for transport and with the translational machinery
(Gao and Keene, 1996; Antic and Keene, 1998). Moreover, we
found one highly conserved CPEB-1 binding site also in the
terminal part of long 3′ UTR, in close proximity to several
motifs recognized by ELAV proteins; this region resulted to
be a novel inducible DTE. Even if AU-rich binding sites were
found in the long 3′ UTR, silencing of hnRNPA2/B1 did not
aﬀect long 3′ UTR mRNA traﬃcking most likely because of
compensatory binding by hnRNP CBF-A (CArG Box binding
Factor A), which was previously shown to be involved in BDNF
mRNA traﬃcking (Raju et al., 2011). In the mid region of the long
3′ UTR, we identiﬁed a previously unknown retention signal able
to overcome the constitutive dendritic targeting signal in the CDS
mediated by Translin. These ﬁndings are in accordance with the
observed increase in BDNF mRNA in dendrites of FMR1 knock-
out mice under resting conditions (Louhivuori et al., 2011) which
might account for an increased susceptibility to epileptic seizures
in these animals (El Idrissi et al., 2005). Notably, FMR1 KO mice
were found to have an exaggerated mTOR and PI3K activation
(Sharma et al., 2010). Since mRNA transport in dendrites can
be mediated by PI3K (Righi et al., 2000), it is conceivable that
the lack of targeting repression by FMRP and the enhanced
PI3K signaling may provide a synergistic eﬀect on BDNF mRNA
transport. In contrast, the dynamics of short 3′ UTR localization
seem to rely on the activation of dormant targeting elements
and proteins, apparently without a soma-retention mechanism.
Interestingly, a similar organization of targeting elements has
been observed in CaMKIIα a prominent dendritically localized
transcript. In fact, two opposing localization signals have been
identiﬁed at the level of CaMKIIα 3′ UTR: a DTE in the ﬁrst
28–56 nts of 3′ UTR, promoting RNA dendritic traﬃcking
(also known as the CNDLE sequence), that is overridden by a
downstream retention signal whose inhibition is relieved after
KCl-induced depolarization (Mori et al., 2000). In CaMKIIα
mRNA, two CPE elements in CaMKIIα 3′ UTR seem to facilitate
mRNA transport and translational activation (Huang et al.,
2002). In addition, it has been reported that the presence of
a translin binding site at the level of the coding region, is
necessary for transport of CaMKIIα mRNA in dendrites (Severt
et al., 1999), as for BDNF mRNA. In BDNF 3′ UTR mRNA, we
found AU-rich regions, ELAV binding sites and a G-quartet-like
structure similar to CaMKIIα (for comparison, see Dictenberg
et al., 2008). Finally, CaMKIIα mRNA might be alternatively
polyadenylated to generate a short or a long 3′ UTR, with the
latter being much more abundant than the former. This striking
parallelism between BDNF and CaMKIIα cis and trans-elements
involved in their activity-dependent subcellular sorting further
supports the “RNA operon theory” (Keene and Tenenbaum,
2002), by which common signals and RBPs are shared by diﬀerent
mRNAs with common functions (e.g., synaptic plasticity and
potentiation).
The results shown here, together with previous ﬁndings from
our laboratory, provide strong evidence that BDNF mRNAs
display both activity-dependence and transcript selectivity.
Transcript selectivity is mediated by signals located in the
5′ UTRs that for some variants may be either permissive to
distal dendritic targeting or, in other variants, may promote
mRNA retention in the soma/proximal dendrites by overriding
localization signals harbored in the CDS and 3′ UTRs
(Chiaruttini et al., 2009). These ﬁndings, together with the role
of both 3′ UTRs in activity-dependent dendritic localization,
as shown here, strongly argue in favor of a mechanism of
BDNF mRNA subcellular sorting regulated by a tripartite
signal (5′ UTRs = selectors, CDS = constitutive DTE, and
3′ UTRs = inducible DTE). In conclusion, we propose a model
in which inducible dendritic targeting signals are harbored in
both 3′ UTRs which respond selectively to diﬀerent extracellular
stimuli, thus proving the basis for a diﬀerential regulation
of BDNF variants for the ﬁne tuning of distal dendritic
compartment plasticity.
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